|
ELU42 Topical Spray Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- Eluciderm Inc1
Indications
- Open Wound1
- Wagner Grade 1 - 21
- Chronic Wound1
- Diabetic Foot Ulcer1
- Diabetes1
O'Fallon, Illinois1 trial
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
Gateway Clinical Trials
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.